PET (positron emission tomography) detection of the effects of aging on the human heart (aim 2 effect of a PPAR [peroxisome proliferator-activated receptor]-alpha agonist on the age related changes in myocardial metabolism and mechanical function)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Fenofibrate (Primary)
- Indications Hypercholesterolaemia; Hypertriglyceridaemia
- Focus Pharmacodynamics
Most Recent Events
- 19 Feb 2009 Biomarkers information updated
- 18 Dec 2008 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Mar 2008 New trial record.